Simplifying Global Compliance
China to Allow Use of Overseas Trial Data in Drug Applications
Clinical Trials Advisor
In a significant policy shift, China plans to accept data from foreign clinical trials in its drug approval process if the drug is already approved overseas.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing